{"paper_id": "6c1aa9863693a1415a8d3996023797c46e1b157d", "metadata": {"title": "Supplementary Information Ilex kaushue and Its Bioactive Component 3,5-Dicaffeoylquinic Acid Protected Mice from Lipopolysaccharide-Induced Acute Lung Injury", "authors": [{"first": "Yu-Li", "middle": [], "last": "Chen", "suffix": "", "affiliation": {"laboratory": "", "institution": "Chang Gung University", "location": {"settlement": "Taoyuan", "country": "Taiwan"}}, "email": ""}, {"first": "Tsong-Long", "middle": [], "last": "Hwang", "suffix": "", "affiliation": {"laboratory": "", "institution": "Chang Gung University", "location": {"settlement": "Taoyuan", "country": "Taiwan"}}, "email": ""}, {"first": "Huang-Ping", "middle": [], "last": "Yu", "suffix": "", "affiliation": {"laboratory": "", "institution": "Chang Gung Memorial Hospital", "location": {"settlement": "Taoyuan", "country": "Taiwan"}}, "email": ""}, {"first": "Jia-You", "middle": [], "last": "Fang", "suffix": "", "affiliation": {"laboratory": "", "institution": "Chang Gung University", "location": {"settlement": "Taoyuan", "country": "Taiwan"}}, "email": ""}, {"first": "Kowit", "middle": ["Yu"], "last": "Chong", "suffix": "", "affiliation": {"laboratory": "", "institution": "Chang Gung University", "location": {"settlement": "Taoyuan", "country": "Taiwan"}}, "email": ""}, {"first": "Yao-Wen", "middle": [], "last": "Chang", "suffix": "", "affiliation": {"laboratory": "", "institution": "Chang Gung University", "location": {"settlement": "Taoyuan", "country": "Taiwan"}}, "email": ""}, {"first": "Chun-Yu", "middle": [], "last": "Chen", "suffix": "", "affiliation": {"laboratory": "", "institution": "Chang Gung Memorial Hospital", "location": {"settlement": "Taoyuan", "country": "Taiwan"}}, "email": ""}, {"first": "Hsuan-Wu", "middle": [], "last": "Yang", "suffix": "", "affiliation": {"laboratory": "", "institution": "Chang Gung University", "location": {"settlement": "Taoyuan", "country": "Taiwan"}}, "email": ""}, {"first": "Wen-Yi", "middle": [], "last": "Chang", "suffix": "", "affiliation": {"laboratory": "", "institution": "Chang Gung University", "location": {"settlement": "Taoyuan", "country": "Taiwan"}}, "email": ""}, {"first": "Pei-Wen", "middle": [], "last": "Hsieh", "suffix": "", "affiliation": {"laboratory": "", "institution": "Chang Gung University", "location": {"settlement": "Taoyuan", "country": "Taiwan"}}, "email": ""}]}, "abstract": [{"text": "Supplementary information Figure S1 Supplementary information Figure S2 Supplementary information Figure S3 Supplementary information Figure S4 Supplementary information Figure S5 Supplementary information Figure S6 ", "cite_spans": [], "ref_spans": [{"start": 26, "end": 35, "text": "Figure S1", "ref_id": null}, {"start": 62, "end": 71, "text": "Figure S2", "ref_id": null}, {"start": 98, "end": 107, "text": "Figure S3", "ref_id": null}, {"start": 134, "end": 143, "text": "Figure S4", "ref_id": null}, {"start": 170, "end": 179, "text": "Figure S5", "ref_id": null}, {"start": 206, "end": 215, "text": "Figure S6", "ref_id": null}], "section": "Abstract"}], "body_text": [{"text": "Human neutrophils were pre-incubated with dimethylsulfoxide (DMSO) or 3,5-DCQA (10 \uf06dM) for 5 min before stimulation with or without fMLF (0.1 \uf06dM) for another 0.5 min. All the Western blotting experiments were performed under the same condition. The targeted proteins were immunoblotted with its specific monoclonal antibody. (A) p38; (B) ERK; (C) Akt. Targeted bands were analyzed using a densitometer and normalized to the corresponding total protein or glyceraldehyde 3-phosphate dehydrogenase (GAPDH). The densitometric data were presented as mean \u00b1 S.E.M. (n = 3-4) . Compared with fMLF group: # p < 0.05 and ## p < 0.01. (4) 3,5-DCQA (6) 4,5-DCQA (7) ", "cite_spans": [{"start": 560, "end": 569, "text": "(n = 3-4)", "ref_id": null}], "ref_spans": [], "section": "Fig. S9. 3,5-DCQA did not inhibited the phosphorylation of MAPKs and Akt in fMLF-activated human neutrohpils."}, {"text": "Thin-layer chromatography (TLC) was used Merck 60 F254 silica gel aluminum backed plates. Flash column chromatography was performed using silica gel (Silicycle, 70-230 mesh or 230-400 mesh). The HPLC system was performed using Jasco PU-1580 intelligent HPLC pump, Jasco AS 1555-10 intelligent sampler, and Jassco UV-1575 UV-Vis detector. Semi-preparative (Develosil, C30-UG-5, 10 mm \u00d7 250 mm) or preparative column (Shiseido, CAPCELL PAK C18 AQ, 20 mm \u00d7 250 mm) were applied for compound purification. The MPLC-flash system was performed using Biotage \u00ae Isolera One with SNAP \u00ae KP-C18-HS 60 g cartridge column, and detection was conducted at 254 and 330 nm. The nuclear magnetic resonance (NMR) spectra using CD3OD, DMSO-d6 and C5D5N as the solvent were obtained on a Bruker AVANCE-400 MHz FT-NMR spectrometer. Low-resolution EI-MS were recorded on a Quattro GC/MS spectrometer having a direct inlet system, low-resolution and high-resolution ESI-MS spectra on a Bruker Daltonics APEX II 30e spectrometer.", "cite_spans": [], "ref_spans": [], "section": "General Experimental Procedures"}, {"text": "IKWE (5.50 g) was dissolved in ddH2O and partitioned with ethyl acetate and n-butanol sequentially to generate the ethyl acetate (EA) (281.3 mg), n-BuOH (2.6 g), and H2O (2.2 g) layers, respectively. The HNE activity assay was employed to monitor sub-fraction bioactivity. Ursolic acid (9) (26.6 mg) and \uf062-sitosterol (16) (6.3 mg) were purified from the EA layer through repeated silica gel chromatography with the CHCl3/MeOH (40/1, v/v) elution system. 1, 2 The n-BuOH layer (2.0 g) was divided into five fractions (Bu-1, 175.7 mg; Bu-2, 127.3 mg; Bu-3, 296.5 mg; Bu-4, 420.3 mg;", "cite_spans": [{"start": 454, "end": 456, "text": "1,", "ref_id": "BIBREF43"}, {"start": 457, "end": 458, "text": "2", "ref_id": "BIBREF44"}], "ref_spans": [], "section": "Bioactivity-guided fractionation"}, {"text": "Bu-5, 720.7 mg) using the gradient MPLC-Flash system (1500 mL H2O/MeOH gradient elution from 100% H2O to 100% MeOH). Menisdaurin F (19) Bu-4-2 with 1% formic acid in 44% MeOH solution at 3.5 mL/min. 8 4, (55.3 mg; rt, 89.2 min) and methyl 4,5-DCQA (8) (11.8 mg; rt, 83.3 min) were purified from Bu-4-3 with 1% formic acid in 43% MeOH solution at 3.0 mL/min. 7, 8 Bu-5 was divided into two fractions (Bu-5-1, 480.6 mg; Bu-5-2, 135.2 mg) with 80% MeOH solution. Bu-5-1 was separated to give latifolioside H (14) (31.6mg; rt, 84.0 min) and latifolioside G (15) (85.0 mg; rt, 86.8 min) with 59% MeOH solution at 3 mL/min. 9 Bu-5-2 was separated to provide kudinoside C (12) (2) (33.1 mg; rt, 23.3 min) were purified directly with 25% MeOH mobile phase and 1% formic acid at 3.0 mL/min from IKWE solution (1.6 g in 20 mL of 25% MeOH solution). 8, 14, 15 For acid hydrolysis, 30 mg of compounds 11, 14 and 15 were heated in 2 mL of 1 M HCl (H2O : p-dioxane = 1 : 1) solution at 95\u00b0C for 30 min. Reaction mixtures were partitioned with EA/H2O three times. Aglycons were obtained from concentrated EA layers via HPLC purification: \uf061-kudinlactone (11-1) (2.3 mg; rt, 7.6 min; 80% MeOH; 2.5 mL/min); kudinchagenin I (11-2) (1.5 mg; rt 16.1 min; 80% MeOH; 2.5 mL/min); siaresinolic acid (14-1) (2.7 mg; rt, 10.1 min; 90% MeOH; 2.5 mL/min); randialic acid B (15-1) (2.8 mg; rt, 22.3 min; 90% MeOH; 2.5 mL/min); sanguisorbigenin (15-2) (2.8 mg; rt, 25.4 min; 90% MeOH; 2.5 mL/min). 9, [11] [12] [13] Compound structures were determined based on 1D/2D NMR and physical properties, in comparison with reference data.", "cite_spans": [{"start": 131, "end": 135, "text": "(19)", "ref_id": "BIBREF62"}, {"start": 199, "end": 203, "text": "8 4,", "ref_id": null}, {"start": 252, "end": 275, "text": "(11.8 mg; rt, 83.3 min)", "ref_id": null}, {"start": 358, "end": 360, "text": "7,", "ref_id": null}, {"start": 361, "end": 362, "text": "8", "ref_id": "BIBREF51"}, {"start": 839, "end": 841, "text": "8,", "ref_id": "BIBREF51"}, {"start": 842, "end": 845, "text": "14,", "ref_id": "BIBREF57"}, {"start": 846, "end": 848, "text": "15", "ref_id": "BIBREF58"}, {"start": 1469, "end": 1471, "text": "9,", "ref_id": "BIBREF52"}, {"start": 1472, "end": 1476, "text": "[11]", "ref_id": "BIBREF54"}, {"start": 1477, "end": 1481, "text": "[12]", "ref_id": "BIBREF55"}, {"start": 1482, "end": 1486, "text": "[13]", "ref_id": "BIBREF56"}], "ref_spans": [], "section": "Bioactivity-guided fractionation"}, {"text": "Neochlorogenic acid (1) Light green powder; Latifolioside H (14) White powder; [\uf061] 23 33.6 (t, C-7), 29.6 (t, C-15), 28.0 (q, C-23), 27.0 (q, C-29), 26.6 (t, C-16), 26.6 (t, C-21), 26.0 (t, C-2), 24.3 (q, C-27), 24.0 (t, C-11), 18.6 (t, C-6), 18.6 (q, Rha C-6'''''), 18 .5 (q, Rha C-6''), 17.3 (q, C-26), 16.9 (q, C-30), 16.6 (q, C-24), 15.7 (q, C-25) . 19.0 (q, C-27), 18.8 (q, C-28), 12.0 (q, C-24), 11.9 (q, C-29).", "cite_spans": [{"start": 267, "end": 269, "text": "18", "ref_id": "BIBREF61"}, {"start": 337, "end": 351, "text": "15.7 (q, C-25)", "ref_id": null}], "ref_spans": [], "section": "Bioactivity-guided fractionation"}, {"text": "Menisdaurin D (17) Colorless plates; [\uf061] 23", "cite_spans": [], "ref_spans": [], "section": "Bioactivity-guided fractionation"}, {"text": "The enzyme inhibition assay modified according to the methods described before. [16] [17] In general, 25 \uf06dl of enzyme solution was added to 50 \uf06dl of drug solution in 96-well plate. After gentle shake for 5 min in the dark, 25 \uf06dl of substrate solution was add to the mixture and incubated until the chlorogenic or fluorogenic absorbance was measured by automatic microplate readers (Thermo Labsystems Multiskan Ascent and HIDEX Multilabel Reader). The blank solution consists of 50 \uf06dL of buffer and 50", "cite_spans": [{"start": 80, "end": 84, "text": "[16]", "ref_id": "BIBREF59"}, {"start": 85, "end": 89, "text": "[17]", "ref_id": "BIBREF60"}], "ref_spans": [], "section": "Supplementary information S2"}, {"text": "\uf06dL of drug solution. Elaspol, CG inhibitor (CALBIOCHEM, 219372) and AEBSF (Enzo, ALX-270-022) were used as positive controls. [19] [20] [21] [22] Inhibition of enzyme activity (%) was determined by the following equation:", "cite_spans": [{"start": 126, "end": 130, "text": "[19]", "ref_id": "BIBREF62"}, {"start": 131, "end": 135, "text": "[20]", "ref_id": "BIBREF63"}, {"start": 136, "end": 140, "text": "[21]", "ref_id": "BIBREF64"}, {"start": 141, "end": 145, "text": "[22]", "ref_id": "BIBREF65"}], "ref_spans": [], "section": "Supplementary information S2"}, {"text": "Abs. diff. between control and blank-Abs. diff. between reaction solution and blank Abs. diff. between control and blank \u00d7 100%", "cite_spans": [], "ref_spans": [], "section": "Supplementary information S2"}, {"text": "The condition of enzymatic reactions such as substrates, buffers, detection wave and final working concentration were further described below.", "cite_spans": [], "ref_spans": [], "section": "Supplementary information S2"}, {"text": "Human neutrophil elastase (Enzo, BML-SE284) and substrate (Enzo, BML-P213)", "cite_spans": [], "ref_spans": [], "section": "Human neutrophil elastase"}, {"text": "were prepared in buffer A. Tested agents were prepared in buffer B. The final", "cite_spans": [], "ref_spans": [], "section": "Human neutrophil elastase"}], "bib_entries": {"BIBREF0": {"ref_id": "b0", "title": "IR vmax (KBr) cm -1 : 3414", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF1": {"ref_id": "b1", "title": "27 (1H, d, J = 8.0 Hz, Glc H-1''''), 6.23 (1H, br s, Rha H-1''), 5.55 (1H, m, H-12)", "authors": [{"first": "H-", "middle": [], "last": "Rha", "suffix": ""}], "year": null, "venue": "", "volume": "6", "issn": "", "pages": "", "other_ids": {}}, "BIBREF2": {"ref_id": "b2", "title": "65 (3H, s, H-27), 1.16 (3H, s, H-23), 1.12 (3H, s, H-29), 1.10 (3H, s, H-24), 1.10 (3H, s, H-26), 0.87 (3H, s, H-25), 0.85 (3H, s, H-30)", "authors": [{"first": "", "middle": [], "last": "Hz", "suffix": ""}], "year": null, "venue": "", "volume": "1", "issn": "", "pages": "", "other_ids": {}}, "BIBREF3": {"ref_id": "b3", "title": "5 (d, Rha C-3''), 72.4 (d, Rha C-4''), 72.4 (d, Rha C-3'''''), 72.2 (d, Rha C-2", "authors": [{"first": "C-", "middle": [], "last": "Ara", "suffix": ""}], "year": null, "venue": "70.0 (d, Rha C-5'')", "volume": "78", "issn": "", "pages": "", "other_ids": {}}, "BIBREF5": {"ref_id": "b5", "title": "UV \uf06cmax (MeOH) nm (log \uf065", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF6": {"ref_id": "b6", "title": "IR vmax (KBr) cm -1 : 3414, 2932", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF7": {"ref_id": "b7", "title": "19 (1H, br s, Rha H-1''), 6.18 (1H, d, J = 8.4 Hz, Glc H-1", "authors": [{"first": "H-", "middle": [], "last": "Rha", "suffix": ""}], "year": null, "venue": "", "volume": "6", "issn": "", "pages": "", "other_ids": {}}, "BIBREF8": {"ref_id": "b8", "title": "0 Hz, Rha H-6''), 1.72 (3H, s, H-27), 1.63 (3H, d, J = 6.0 Hz, Rha H-6", "authors": [{"first": "D", "middle": [], "last": "3h", "suffix": ""}, {"first": "J", "middle": ["="], "last": "", "suffix": ""}], "year": null, "venue": "", "volume": "1", "issn": "", "pages": "", "other_ids": {}}, "BIBREF9": {"ref_id": "b9", "title": "C-3), 82.2 (d, Ara C-3'), 80.0 (d, Glc C-3''''), 78.9 (d, Glc C-5''''), 78.4 (d, Glc-5'''), 78.1 (d, Glc C-3'''), 75.1 (d, Glc C-2''''), 74.8 (d, Glc C-2'''), 74.6 (d, Ara C-2')", "authors": [], "year": null, "venue": "72.5 (d, Rha C-4''), 72.4 (d, Rha C-3''''')", "volume": "104", "issn": "", "pages": "", "other_ids": {}}, "BIBREF12": {"ref_id": "b12", "title": "8 (s, C-8)", "authors": [], "year": null, "venue": "02~3.18 (4H, m, H-2'~H-5'), 2.48 (1H, m, H-2a), 2.11 (2H, m, H-2b, H5a), 1.77 (1H, m, H-3a), 1.60 (1H, m, H-5b), 1.41 (1H, m, H-3b). 13 C NMR (DMSO-d6, 100 MHz) \u03b4: 165.7 (s, C-1)", "volume": "117", "issn": "", "pages": "", "other_ids": {}}, "BIBREF14": {"ref_id": "b14", "title": "UV \uf06cmax (MeOH) nm (log \uf065", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF15": {"ref_id": "b15", "title": "IR vmax (KBr) cm -1 : 3343", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF16": {"ref_id": "b16", "title": "H-5a), 2.06 (1H, ddd, J = 13.2, 8.0, 6.2 Hz, H-5b). 13 C NMR (CD3OD, 100 MHz) \u03b4: 157.1 (s, C-1)", "authors": [], "year": null, "venue": "", "volume": "140", "issn": "", "pages": "", "other_ids": {}}, "BIBREF18": {"ref_id": "b18", "title": "UV \uf06cmax (MeOH) nm (log \uf065", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF19": {"ref_id": "b19", "title": "3H, s, H-29), 1.54 (3H, s, H-30)", "authors": [], "year": null, "venue": "", "volume": "1", "issn": "", "pages": "", "other_ids": {}}, "BIBREF20": {"ref_id": "b20", "title": "9 (s, C-20), 80.0 (d, C-3), 74.1 (s, C-19), 55.1 (d, C-5), 54.6 (d, C-9), 43.8 (s, C-17), 42.2 (s, C-8), 42.2 (s, C-14), 39.5 (s, C-4)", "authors": [], "year": null, "venue": "37.0 (s, C-10), 33.0 (t, C-7)", "volume": "127", "issn": "", "pages": "", "other_ids": {}}, "BIBREF22": {"ref_id": "b22", "title": "UV \uf06cmax (MeOH) nm (log \uf065", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF23": {"ref_id": "b23", "title": "IR vmax (KBr) cm -1 : 3434", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF24": {"ref_id": "b24", "title": "89 (1H, d, J = 10", "authors": [{"first": "(", "middle": [], "last": "1h", "suffix": ""}, {"first": "", "middle": [], "last": "Dd", "suffix": ""}], "year": null, "venue": "", "volume": "4", "issn": "", "pages": "", "other_ids": {}}, "BIBREF25": {"ref_id": "b25", "title": "3 (s, C-13), 131.5 (d, C-12), 129.2 (s, C-18), 125.8 (d, C-11)", "authors": [], "year": null, "venue": "0.87 (3H, s, H-25), 0.76 (3H, s, H-26). 13 C NMR (C5D5N, 100 MHz) \u03b4: 175.0 (s, C-28)", "volume": "146", "issn": "", "pages": "", "other_ids": {}}, "BIBREF27": {"ref_id": "b27", "title": "UV \uf06cmax (MeOH) nm (log \uf065", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF28": {"ref_id": "b28", "title": "KBr) cm -1 : 3430", "authors": [{"first": "", "middle": [], "last": "Ir", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF29": {"ref_id": "b29", "title": "H-3), 1.68 (3H, s, H-27), 1.26 (3H, s, H-23), 1.21 (3H, s, H-29), 1.14 (3H, s, H-30), 1.10 (3H, s, H-26), 1.05 (3H, s, H-24), 0.94 (3H, s, H-25)", "authors": [{"first": "", "middle": [], "last": "Mp", "suffix": ""}], "year": null, "venue": "3.66 (2H, m, H-18, H-19), 3.46 (1H, dd, J = 11.2, 5.2 Hz", "volume": "13", "issn": "", "pages": "271--272", "other_ids": {}}, "BIBREF31": {"ref_id": "b31", "title": "UV \uf06cmax (MeOH) nm (log \uf065", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF33": {"ref_id": "b33", "title": "3H, s, H-29), 1.26 (3H, s, H-23), 1.16 (3H, s, H-27), 1.13 (3H, d, J = 6.8 Hz, H-30), 1.07 (3H, s, H-26), 1.05 (3H, s, H-24), 0.91 (3H, s, H-25)", "authors": [], "year": null, "venue": "C NMR (C5D5N, 100 MHz) \u03b4: 178.6 (s, C-28), 139.5 (s, C-13)", "volume": "13", "issn": "", "pages": "", "other_ids": {}}, "BIBREF35": {"ref_id": "b35", "title": "UV \uf06cmax (MeOH) nm (log \uf065", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF36": {"ref_id": "b36", "title": "3H, s, H-30), 1.22 (3H, s, H-23), 1.16 (3H, s, H-27), 1.05 (3H, s, H-26), 1.04 (3H, s, H-25), 0.92 (3H, s, H-24); 13 C NMR (C5D5N, 100 MHz) \u03b4: 179.8 (s, C-28), 138.5 (s, C-13), 129.0 (s, C-19)", "authors": [], "year": null, "venue": "18.0 (q, C-26), 17.4 (q, C-29)", "volume": "127", "issn": "", "pages": "", "other_ids": {}}, "BIBREF37": {"ref_id": "b37", "title": "Human proteinase 3 (Merk, 539483), substrate (Enzo, BML-P303) and tested agents were all prepared in prepared in buffer D. The final concentrations of enzyme, substrate are 10 nM and 100 \uf06dM, respectively. The absorption at 405 nm was", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF38": {"ref_id": "b38", "title": "T7009-100KU) and substrate (Merck, 605211) were prepared in buffer A. Tested agents were prepared in buffer B. The final concentrations of enzyme", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF39": {"ref_id": "b39", "title": "S9761) were prepared in buffer A. Tested agents were prepared in buffer B. The final concentrations of enzyme, substrate are 5 nM and 5 \uf06dM, respectively. The ex/em waves at 340/460 nm was measured 30 min after the enzymatic reaction began", "authors": [{"first": "C4129", "middle": [], "last": "Sigma-Aldrich", "suffix": ""}, {"first": "", "middle": [], "last": "Sigma-Aldrich", "suffix": ""}], "year": null, "venue": "Buffers Buffer A: 20mM Tris-HCL", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF40": {"ref_id": "b40", "title": "Buffer B: 20mM Tris-HCL, pH 7.4, 0.1% NaN3, 5 mM CaCl2", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF41": {"ref_id": "b41", "title": "Buffer C: 100 mM Tris-HCl, 1.6 M NaCl", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF42": {"ref_id": "b42", "title": "Buffer D: 100 mM HEPES, pH 7.5, 500 mM NaCl, 10% DMSO, 170 \uf06dM Reference", "authors": [], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}, "BIBREF43": {"ref_id": "b43", "title": "LC-MS method for the simultaneous quantitation of the anti-inflammatory constituents in oregano (Origanum species)", "authors": [{"first": "D", "middle": [], "last": "Shen", "suffix": ""}], "year": 2010, "venue": "J. Agric. Food Chem", "volume": "58", "issn": "", "pages": "7119--7125", "other_ids": {}}, "BIBREF44": {"ref_id": "b44", "title": "Isolation of stigmasterol and \uf062-sitosterol from the dichloromethane extract of Rubus suavissimus", "authors": [{"first": "V", "middle": ["S"], "last": "Chaturvedula", "suffix": ""}, {"first": "I", "middle": [], "last": "Prakash", "suffix": ""}], "year": 2012, "venue": "Int. Curr. Pharmaceut. J", "volume": "1", "issn": "", "pages": "239--242", "other_ids": {}}, "BIBREF45": {"ref_id": "b45", "title": "-cyclohexen-1-ylideneacetonitrile, form Cocculus lauriforium DC", "authors": [{"first": "M", "middle": [], "last": "Yogo", "suffix": ""}, {"first": "S", "middle": [], "last": "Ishiguro", "suffix": ""}, {"first": "H", "middle": [], "last": "Murata", "suffix": ""}, {"first": "H", "middle": [], "last": "Furukawa", "suffix": ""}, {"first": "", "middle": [], "last": "Coclauril", "suffix": ""}], "year": 1990, "venue": "Chem. Pharm. Bull", "volume": "38", "issn": "2", "pages": "225--226", "other_ids": {}}, "BIBREF46": {"ref_id": "b46", "title": "Structure of a new cyanoglucoside from Ilex warburgii Loesn", "authors": [{"first": "K", "middle": [], "last": "Ueda", "suffix": ""}, {"first": "K", "middle": [], "last": "Yasutomi", "suffix": ""}, {"first": "I", "middle": [], "last": "Mori", "suffix": ""}], "year": 1983, "venue": "Chem. Lett", "volume": "12", "issn": "", "pages": "149--150", "other_ids": {}}, "BIBREF47": {"ref_id": "b47", "title": "Cyanogenic glycosides and menisdaurin from Guazuma ulmifolia, Ostrya virginiana, Tiquilia plicata, and Tiquilia canescens", "authors": [{"first": "D", "middle": ["S"], "last": "Seigler", "suffix": ""}], "year": 2005, "venue": "Phytochemistry", "volume": "66", "issn": "", "pages": "1567--1580", "other_ids": {}}, "BIBREF48": {"ref_id": "b48", "title": "Four new chclohexylideneacetonitrile derivatives from the hypocotyls of mangrove (Bruguiera gymnorrhiza)", "authors": [{"first": "X", "middle": ["X"], "last": "Yi", "suffix": ""}], "year": 2015, "venue": "Molecules", "volume": "20", "issn": "", "pages": "14565--14575", "other_ids": {}}, "BIBREF50": {"ref_id": "b50", "title": "Potent Hepatoprotective activity in experimental liver injury models", "authors": [], "year": 1996, "venue": "Biol. Pharm. Bull", "volume": "19", "issn": "", "pages": "1479--1484", "other_ids": {}}, "BIBREF51": {"ref_id": "b51", "title": "Caffeoylquinic acid derevatives isolated from the aerial parts of Gynura divaricata and their yeast \uf061-glucosidase and PTP1B inhibitory activity", "authors": [{"first": "J", "middle": [], "last": "Chen", "suffix": ""}], "year": 2014, "venue": "Fitoterapia", "volume": "99", "issn": "", "pages": "1--6", "other_ids": {}}, "BIBREF52": {"ref_id": "b52", "title": "Triterpenoid saponins from Ilex latifolia", "authors": [{"first": "M", "middle": ["A"], "last": "Ouyang", "suffix": ""}, {"first": "Y", "middle": ["Q"], "last": "Liu", "suffix": ""}, {"first": "H", "middle": ["Q"], "last": "Wang", "suffix": ""}, {"first": "C", "middle": ["R"], "last": "Yang", "suffix": ""}], "year": 1998, "venue": "Phytochemistry", "volume": "49", "issn": "", "pages": "2483--2486", "other_ids": {}}, "BIBREF53": {"ref_id": "b53", "title": "Triterpenes and triterpenoid glycosides from the leaves of Ilex kudincha", "authors": [{"first": "M", "middle": ["A"], "last": "Ouyang", "suffix": ""}, {"first": "C", "middle": ["R"], "last": "Yang", "suffix": ""}, {"first": "Z", "middle": ["Y"], "last": "Chen", "suffix": ""}, {"first": "H", "middle": ["Q"], "last": "Wang", "suffix": ""}], "year": 1996, "venue": "Phytochemistry", "volume": "41", "issn": "", "pages": "871--877", "other_ids": {}}, "BIBREF54": {"ref_id": "b54", "title": "Triterpenoid glycosides from Ilex kudincha", "authors": [{"first": "M", "middle": ["A"], "last": "Ouyang", "suffix": ""}, {"first": "H", "middle": ["Q"], "last": "Wang", "suffix": ""}, {"first": "Z", "middle": ["L"], "last": "Chen", "suffix": ""}, {"first": "C", "middle": ["R"], "last": "Yang", "suffix": ""}], "year": 1996, "venue": "Phytochemistry", "volume": "43", "issn": "", "pages": "443--445", "other_ids": {}}, "BIBREF55": {"ref_id": "b55", "title": "Triterpene glycosides from the roots of Sanguisorba officinalis", "authors": [{"first": "Y", "middle": [], "last": "Mimaki", "suffix": ""}], "year": 2001, "venue": "Phytochemistry", "volume": "57", "issn": "", "pages": "773--779", "other_ids": {}}, "BIBREF56": {"ref_id": "b56", "title": "Structural identification of kudinchagenin I", "authors": [{"first": "Y", "middle": ["X"], "last": "Wen", "suffix": ""}, {"first": "X", "middle": ["Y"], "last": "Liang", "suffix": ""}, {"first": "G", "middle": ["R"], "last": "Cheng", "suffix": ""}], "year": 1999, "venue": "Acta Bot. Sin", "volume": "41", "issn": "", "pages": "206--208", "other_ids": {}}, "BIBREF57": {"ref_id": "b57", "title": "The anti-thrombotic active constituents from Centella asiatica", "authors": [{"first": "T", "middle": [], "last": "Satake", "suffix": ""}, {"first": "K", "middle": [], "last": "Kamiya", "suffix": ""}, {"first": "Y", "middle": [], "last": "An", "suffix": ""}, {"first": "T", "middle": [], "last": "Oishi", "suffix": ""}, {"first": "J", "middle": [], "last": "Yamamoto", "suffix": ""}], "year": 2007, "venue": "Biol. Pharm. Bull", "volume": "30", "issn": "", "pages": "935--940", "other_ids": {}}, "BIBREF58": {"ref_id": "b58", "title": "UFLC/MS-IT-TOF guided isolation of anti-HBV active chlorogenic acid analogues from Artemisia capillaris as a traditional Chinese herb for the treatment of hepatitis", "authors": [{"first": "Y", "middle": [], "last": "Zhao", "suffix": ""}], "year": 2014, "venue": "J. Ethnopharmacol", "volume": "156", "issn": "", "pages": "147--154", "other_ids": {}}, "BIBREF59": {"ref_id": "b59", "title": "AZD9668: pharmacological characterization of a novel oral inhibitor of neutrophil elastase", "authors": [{"first": "T", "middle": [], "last": "Stevens", "suffix": ""}], "year": 2011, "venue": "J. Pharmacol. Exp. Ther", "volume": "339", "issn": "", "pages": "313--320", "other_ids": {}}, "BIBREF60": {"ref_id": "b60", "title": "Substrate and inhibitor studies on proteinase 3", "authors": [{"first": "C", "middle": ["M"], "last": "Kam", "suffix": ""}], "year": 1992, "venue": "FEBS Lett", "volume": "297", "issn": "", "pages": "119--123", "other_ids": {}}, "BIBREF61": {"ref_id": "b61", "title": "Therapeutic effects of pyroolidine dithiocarbamate on acute lung injury in rabbits", "authors": [{"first": "M", "middle": [], "last": "Wang", "suffix": ""}], "year": 2011, "venue": "J. Transl. Med", "volume": "9", "issn": "", "pages": "", "other_ids": {"DOI": ["10.1186/1479-5876-9-61"]}}, "BIBREF62": {"ref_id": "b62", "title": "ONO-5046, a novel inhibitor of human neutrophil elastase", "authors": [{"first": "K", "middle": [], "last": "Kawabata", "suffix": ""}], "year": 1991, "venue": "Biochem. Biophys. Res. Commun", "volume": "177", "issn": "", "pages": "814--820", "other_ids": {}}, "BIBREF63": {"ref_id": "b63", "title": "Nonpeptide inhibitors of cathepsin G: optimization of a novel \uf062-ketophosphonic acid lead by structure-based drug design", "authors": [{"first": "M", "middle": ["N"], "last": "Greco", "suffix": ""}], "year": 2002, "venue": "J. Am. Chem. Soc", "volume": "124", "issn": "", "pages": "3810--3811", "other_ids": {}}, "BIBREF64": {"ref_id": "b64", "title": "Irreversible inhibitors of serine, systeine, and threonine proteases", "authors": [{"first": "J", "middle": ["C"], "last": "Powers", "suffix": ""}], "year": 2002, "venue": "Chem. Rev", "volume": "102", "issn": "", "pages": "4639--4750", "other_ids": {}}, "BIBREF65": {"ref_id": "b65", "title": "Evaluation of two inhibitors of invasion: LY311727 [3-(3-acetamide-1-benzyl-2-ethyl-indolyl-5-oxy)propane phsphonic acid] and AEBSF", "authors": [{"first": "B", "middle": ["R"], "last": "Rafael", "suffix": ""}, {"first": "O", "middle": [], "last": "Jorge", "suffix": ""}, {"first": "E", "middle": ["G"], "last": "Jorge", "suffix": ""}], "year": null, "venue": "", "volume": "", "issn": "", "pages": "", "other_ids": {}}}, "ref_entries": {"FIGREF0": {"text": "Calibration curves of three chemical reference standards.", "latex": null, "type": "figure"}, "FIGREF1": {"text": "Quality control index of water extracts from different Kudingcha materials. (A) Three Kudincha materials; (B) Index of QC. a Concentration necessary for 50 % inhibition at \uf06dg/ml. Data were presented as mean \u00b1 S.E.M. (n \u2265 3).", "latex": null, "type": "figure"}, "FIGREF2": {"text": "The effects of post-treated 3,5-DCQA on LPS-induced ALI in mice. Mice received post-treatment of vehicle or 3,5-DCQA (50 mg/kg) intraperitoneally 1hour after intratracheal instillation of LPS. After 6 hours of LPS treatment, mice were anesthetized and their chests were opened. Whole lungs were obtained immediately. Left lobe was then dissected for histology or MPO activity. Right lobes were applied for W/D weight ratio. (A) Histological examination (scale bar = 50 \uf06dM); (B) (C) Lung W/D weight ratio and MPO activity. Data were presented as mean \u00b1 S.E.M. (n = 3 for control; n = 6 for LPS or 3,5-DCQA groups). Compared with vehicle group: ## p < 0.01; Compared with LPS group: * p < 0.05 and ** p < 0.01.", "latex": null, "type": "figure"}, "FIGREF3": {"text": "), menisdaurin D (17) (31.3 mg; rt, 51.2 min) and menisdaurin (18) (36.5 mg; rt, 56.1 min) were derived from fraction Bu-2 with 18% MeOH aqueous solution at 3 mL/min. 3-6 Bu-4 was further divided into 3 fractions (Bu-4-1, 55.0 mg; Bu-4-2, 33.8 mg; Bu-4-3, 136.2 mg) with mobile phase consisting of 1% formic acid in 48% MeOH solution. 3,4-DCQA (4) (38.5 mg; rt, 72.0 min) and methyl 3,4-DCQA (5) (5.3 mg; rt, 68.8 min) were purified from Bu-4-1 with 1% formic acid in 40% MeOH solution at 3 mL/min. 7,8 3,5-DCQA (6) (26.0 mg; rt, 49.2 min) was obtained from", "latex": null, "type": "figure"}, "FIGREF4": {"text": "(27.0 mg; rt, 38.8 min), kudinoside A (10) (45.0 mg; 42.8 min), kudinoside D (11) (11.5 mg; 49.6 min) and kudinoside F (13) (20.6 mg; 51.7 min) with 75% MeOH solution at 3.5 mL/min. 10-13 3-CQA (1) (26.7 mg; rt, 9.1 min), 5-CQA (3) (57.3 mg; rt, 16.6 min) and 4-CQA", "latex": null, "type": "figure"}, "FIGREF5": {"text": "[\uf061] 22 D: -51.7\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log\uf065): 207 (3.92), 218 (3.98), 244 (3.83), 295 (3.91), 328 (4.02); IR vmax (KBr) cm -1 : 3421, 1697, 1606, 1523, 1446, 983; Mp: 202-203\u00b0; ESIMS: m/z 353.1 [M-H] + ; 1 H NMR (CD3OD, 400 MHz) \u03b4: 7.58 (1H, d, J = 16.0 Hz, H-3'), 7.05 (1H, d, J = 2.0 Hz, H-5'),6.94 (1H, dd, J = 8.4, 2.0 Hz,,6.78 (1H, d, J = 8.4 Hz,,6.31 (1H, d, J =   16.0 Hz,,5.37 (1H, m, H-3),4.17 (1H, m, H-5),3.66 (1H, dd, J = 8.4, 3.2 Hz,, 2.14~2.19 (3H, m, H-2a, H-6a, H-6b), 1.97 (1H, m, H-2b); 13 C NMR (CD3OD, 100 MHz) \u03b4: 178.3 (s, C-7), 169.82.0\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log \uf065): 207 (4.09), 218 (3.98), 244 (3.97), 295 (4.10), 328 (4.19); IR vmax (KBr) cm -1 : 3414, 1695, 1606, 1520, 1447, 978; Mp: 205-206\u00b0; ESIMS: m/z 353.3 [M-H] + ; 1 H NMR (CD3OD, 400 MHz) \u03b4: 7.64 (1H, d, J = 16.0 Hz, H-3'), 7.07 (1H, d, J = 1.6 Hz, H-5'60.3\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log \uf065):206 (3.86), 218 (4.28), 244 (4.12), 297 (4.18), 328 (4.29); IR vmax (KBr) cm -1 : 3409, 1697, 1604, 1521, 1447, 979; Mp: 210-202\u00b0; ESIMS: m/z 353.3 [M-H] + ; 1 H NMR (CD3OD, 400 MHz) \u03b4: 7.56 (1H, d, J = 16.0 Hz, H-3'), 7.06 (1H, s, H-5'), 6.95 (1H, d, J = 8.0 Hz, H-9'), 6.79 (1H, d, J = 8.0 Hz, H-8'), 6.26 (1H, d, J = 16.0 Hz, H-2'), 5.35 (1H, m, H-5), 4.19 (1H, m, H-3), 3.75 (1H, dd, J = 8.4, 2.4 Hz, H-4), 2.04~2.27 (4H, m, H-2a, H-2b, H-6a, H-6b); 13 C NMR (CD3OD, 100 MHz) \u03b4: 177.979; Mp: 153-154\u00b0; ESIMS: m/z 515.2 [M-H] + ; 1 H NMR (CD3OD, 400 MHz) \u03b4: 7.58 (1H, d, J = 16.0 Hz, H-3'), 7.55 (1H, d, J = 16.0 Hz, H-3''), 7.04 (1H, d, J = 1.2 Hz, H-5'), 7.02 (1H, d, J = 1.2 Hz, H-5''), 6.92 (1H, dd, J = 8.0, 1.2 Hz, H-9'), 6.87 (1H, dd, J = 8.0, 1.2 Hz, H-9''), 6.77 (1H, d, J = 8.0 Hz, H-8'), 6.73 (1H, d, J = 8.0 Hz, H-8''), 6.29 (1H, d, J = 16.0 Hz, H-2''), 6.25 (1H, d, J = 16.0 Hz, H-2'), 5.65 (1H, m, H-3), 5.01 (1H, dd, J = 8.8, 2.8 Hz, H-4), 4.39 (1H, m, H-5), 2.14~2.39 (4H, m, H-2a, H-2b, H-6a, H-6b); 13 C NMR (CD3OD, 100 MHz) \u03b4: 178.0 (s, C-7), 168.-240.4\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log \uf065): 207 (4.37), 218 (4.45), 244 (4.30), 296 (4.42), 328 (4.54); IR vmax (KBr) cm -10~2.38 (4H, m, H-2a, H-2b, H-6a, H-6b); 13 C NMR (CD3OD, 100 MHz) \u03b4: 191.9\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log \uf065): 207 (4.30), 218 (4.39), 244 (4.24), 297 (4.37), 328 (4.50); IR vmax (KBr) cm -1 : 3319, 1692, 1603, 1523, 1446, 977; Mp: 163-164\u00b0; ESIMS: m/z 515.2 [M-H] + ; 1 H NMR (CD3OD, 400 MHz) \u03b4: 7.62 (1H, d, J = 16.0 Hz, H-3'), 7.58 (1H, d, J = 16.0 Hz, H-3''), 7.07 (2H, s, H-5', H-5''), 6.98 (1H, dd, J = 8.4, 2.0 Hz, H-9'), 6.96 (1H, dd, 170.4\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log \uf065): 207 (4.37), 218 (4.43), 246 (4.28), 297 (4.40), 328 (4.51); IR vmax (KBr) cm -1 : 3369, 1694, 1604, 1523, 1446, 980; Mp: 158-159\u00b0; ESIMS: m/z 515.2 [M-H] + ; 1 H NMR (CD3OD, 400 MHz) \u03b4: 7.60 (1H, d, J = 16.0 Hz, H-3'), 7.52 (1H, d, J = 16.0 Hz, H-3''), 7.03 (1H, s, H-5'), 7.01 (1H, s, H-5''), 6.92 (1H, d, J = 7.6 Hz, H-9'), 6.90 (1H, d, J = 7.6 Hz, H-9''), 6.75 (2H, d, J = 7.6 Hz, H-8', H-8''), 6.29 (1H, d, J = 16.CD3OD, 100 MHz) \u03b4: 176.8 (s, C-7), 168.5 (s, C-1'), 168.2 (s, C-1''), 149.6 (s, C-7'162.7\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log \uf065): 206 (4.32), 218 (4.41), 245 (4.27), 298 (4.39), 329 (4.52); IR vmax (KBr) cm -1 : 3424, 1693, 1604, 1522, 1445, 982; Mp: 156-157\u00b0; ESIMS: m/z 529.3 [M-H] + ; 1 H NMR (CD3OD, 400 MHz) \u03b4: 7.61 (1H, d, J = 16.0 Hz, H-3'), 7.51 (1H, d, J = 16.0 Hz, H-3''), 7.04 (1H, d, J = 2.0 Hz, H-5'), 7.01 (1H, d, J = 2.0 Hz, H-5''), 6.94 (H, dd, J = 8.0, 2.0 Hz, H-9'), 6.92 (1H, dd, J = 8.0, 2.0 Hz, H-9''), 6.76 (2H, d, J = 8.0 Hz, H-8', H-8''), 6.30 (1H, d, J = 16.0 Hz, H-2''), 6.18 (1H, d, J = 16.0 Hz, H-2'), 5.53 (1H, m, H-5), 5.11 (1H, dd, J = 8.0, 2.8 Hz, H-4), 4.35 (1H, m, H-3), 2.34 (3H, s, -COOCH3), 2.07~2.34 (4H, m, H-2a, H-2b, H-6a, H-6b); 13 C NMR (CD3OD, 100 MHz) \u03b4: , C-5''), 114.7 (d, C-2'), 114.5 (d, C-2''), 75.7 (d, C-4), 74.7 (s, C-1), 69.1 (d, C-87.4\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log \uf065): 207 (3.59); IR vmax (KBr) cm -1 : 3421, 2927, 2856, 1691, 1459, 1387, 1091; Mp: 276-277\u00b0; Rf = 0.37 (CHCl3 : MeOH = 40 : 1, v/v); ESIMS: m/z 455.4 [M-H] + ; 1 H NMR (C5D5N, 400 MHz) \u03b4: 5.50 (1H, br s, H-12), 3.46 (1H, dd, J =9.6, 6.0 Hz, H-3), 2.64 (1H, d, J =11.2 Hz, H-18), 1.25 (3H, s, H-23), 1.24 (3H, s, H-27), 1.06 (3H, s, H-26), 1.03 (3H, s, H-24), 1.02 (3H, d, J = 6.4 Hz, H-29), 0.97 (3H, d, J = 5.6 Hz, H-30); 13 C NMR (C5D5N, 100 MHz) \u03b4: 179.9 (s, C-28), 139.3 (s, C-13), 125.6 (d, C-12), 78.-126.6\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log \uf065): 207 (4.09), 277 (3.85), 255 (3.69); IR vmax (KBr) cm -1 : 3398, 2942, 2875, 1732, 1641, -79.0\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log \uf065): 220 (3.77), 259 (4.26); IR vmax (KBr) cm -1 : 3431, 2940, 1739, 1646, 1454, 1395, 1073; -86.5\u00b0 (c = 0.05, MeOH); UV \uf06cmax (MeOH) nm (log \uf065): 207 (3.88), 225 (3.67); IR vmax (KBr) cm -1 : 3402, 2943, 2874, 1730, 1642, 1452, '''), 78.4 (d, Glc C-5'''), 78.3 (d, Glc C-3'''), 78.2 (d, Glc-3''''), 76.1 (d, Glc C-2''''), 74.3 (d, Ara C-2'), 74.2 (s, C-19), 73.9 (d, Rha C-4''), 72.5 (d, Rha C-3''), 72.4 (d, Rha C-2''), 70.8 (d, Glc C-4'''), 70.4 (d, Glc C-4''''), 69.8 (d, Rha C-5''), 69.4 (d, Ara C-4'), 66.0 (d, C-12), 65.8 (t, Ara C-5'), 62.3 (t, Glc C-6'''), 61.8 (t, Glc-6''''), 56.3 (d, C-5), 44.8 (d, C-9), 44.1 (s, C-17), 43.9 (s, C-14), 41.7 (s, C-8), 39.5 (s, C-4), 39.2 (t, C-1),37.0 (s, C-10), 35.5 (t, C-7), 32.8 (t, C-22), 28.8 (t, C-2), 28.8 (t, C-15), 28.3 (t, C-21), 28.0 (q, C-23), 26.7 (t, C-16), 26.2 (t, C-11), 25.2 (q, C-29), 23.4 (q, C-27), 19.5 (q, C-30), 18.5 (t, C-6), 18.3 (q, Rha C-6''), 18.2 (q, C-26), 17.1 (q, C-24),16.8 (q, C-25).", "latex": null, "type": "figure"}, "FIGREF6": {"text": "NMR (C5D5N, 100 MHz) \u03b4: 175.4 (s, C-28), 143.5 (s, C-13), 135.6 (s, C-18), 104.9 (d, Ara C-1'), 104.8 (d, Glc C-1'''), 101.9 (d, Rha C-1''), 88.0 (d, C-3), 85.3 (s, C-20), 82.4 (d, Ara C-3'), 78.6 (d, Glc C-5'''), 78.2 (d, Glc C-3'''), 74.9 (d, Glc C-2'''), 74.6 (d, Ara C-2'), 73.9 (d, Rha C-4''), 73.2 (s, C-19), 72.5 (d, Rha C-2''), 72.5 (d, Rha C-3''), 71.5 (d, Glc C-4'''), 71.4 (d, C-11), 70.0 (d, Rha C-5''), 68.3 (d, Ara C-4'), 65.0 (t, Ara C-5'), 62.5 (t, Glc C-6'''), 55.9 (d, C-5), 50.1 (d, C-9), 46.2 (s, C-17), 45.5 (s, C-14), 42.7 (s, C-8), 39.5 (s, C-4), 39.0 (t, C-1), 37.1 (s, C-10), 35.1 (t, C-7), 33.5 (t, C-12), 32.4 (t, C-22), 29.2 (t, C-15), 29.2 (t, C-21), 27.9 (q, C-23), 26.9 (t, C-2), 26.6 (t, C-16), 26.5 (q, C-29), 21.5 (q, C-27), 20.2 (q, C-30), 18.6 (q, Rha C-6''), 18.4 (t, C-6), 17.1 (q, C-26), 16.9 (q, C-25),16.8 (q, C-24).", "latex": null, "type": "figure"}, "FIGREF7": {"text": "CHCl3); UV \uf06cmax (MeOH) nm (log \uf065): 245 (2.84); IR vmax (KBr) cm -1 : 3427, 2936, 2868, 1463, 1380, 1051, 1023; Mp: 141-142\u00b0; Rf = 0.55 (CHCl3 : MeOH = 40 : 1, v/v); 1 H NMR (C5D5N, 400 MHz) \u03b4: 5.35 (1H, m, H-6), 3.53 (1H, m, H-3), 1.01 (3H, s, H-29), 0.92 (3H, d, J = 6.4 Hz, H-19), 0.85 (3H, t, J = 7.2 Hz, H-24), 0.84 (3H, d, J = 7.2 Hz, H-26), 0.81 (3H, d, J = 7.2 Hz, H-27), 0.69 (3H, s, H-28). 13 C NMR (C5D5N, 100 MHz) \u03b4: 140., C-21), 24.3 (t, C-15), 23.1 (t, C-23), 21.1 (t, C-11),19.8 (q, C-19),19.4 (q, C-26),", "latex": null, "type": "figure"}, "TABREF1": {"text": "1 H and 13 C NMR data of menisdaurin and menisdaurin F Table S3. HNE inhibitory activities of caffeic acid analogs HNE inhibition at 30 \uf06dM. CA, caffeic acid; p-CA, p-coumaric acid; 3-HCA, 3-hydroxycinnamic acid; FA, ferulic acid; RA, rosaminiric acid. All data were presented as mean \u00b1 S.E.M. (n \u2265 3).Data were presented as mean \u00b1 S.E.M. (n \u2265 3).", "latex": null, "type": "table"}, "TABREF2": {"text": "IR vmax (KBr) cm-1 : 3411, 2939, 1729, 1635, 1456, 1366, 1076,   1024; Mp: 261-262\u00b0; ESIMS: m/z 925.6 [M-H] + ; 1 H NMR (C5D5N, 400 MHz) \u03b4: 6.22(1H, br s, Rha H-1''),5.13 (1H, d, J = 7.6 Hz, 4.95 (1H, d, J = 7.6 Hz,", "latex": null, "type": "table"}, "TABREF3": {"text": "Table S1 Table S1. 1 H and 13 C NMR data of menisdaurin and menisdaurin F", "latex": null, "type": "table", "html": "<html><body><table><tr><td>\u00a0</td><td>Menisdaurine </td><td>\u00a0</td><td>Menisdaurine F </td><td>\u00a0</td></tr><tr><td>Position </td><td>1H </td><td>13C </td><td>1H </td><td>13C </td></tr><tr><td>1 </td><td>\u00a0</td><td>157.1, s </td><td>\u00a0</td><td>159.1, s </td></tr><tr><td>2 </td><td>6.32, d, J=10.0 Hz </td><td>127.7, d </td><td>6.57, dd, J=10.0, 2.0 Hz </td><td>124.5, d </td></tr><tr><td>3 </td><td>6.24, dd, J=10.0, 3.2 Hz </td><td>140.6, d </td><td>6.24, d, J=10.0 Hz </td><td>143.3, d </td></tr><tr><td>4 </td><td>4.40, m </td><td>65.3, d </td><td>4.49, m </td><td>67.6, d </td></tr><tr><td>\u00a0</td><td>2.30, ddd, J=13.2, 5.2, 4.4 Hz </td><td>\u00a0</td><td>2.56, m </td><td>\u00a0</td></tr><tr><td>5 </td><td>2.06, ddd, J=13.2, 8.0, 6.2 Hz </td><td>36.1, t </td><td>1.66, m </td><td>36.4, t </td></tr><tr><td>6 </td><td>4.96, ddd, J=8.0, 2.4, 1.2 Hz </td><td>72.5, d </td><td>4.62, m </td><td>74.8, d </td></tr><tr><td>7 </td><td>5.55, s </td><td>96.8, d </td><td>5.77, s </td><td>93.7, d </td></tr><tr><td>8 </td><td>\u00a0</td><td>118.0, s </td><td>\u00a0</td><td>117.9, s </td></tr><tr><td>1' </td><td>4.58, d, J=6.4 Hz </td><td>101.5, d </td><td>4.48, d, J=8.0 Hz </td><td>102.6, d </td></tr><tr><td>2' </td><td>\u00a0</td><td>74.4, d </td><td>\u00a0</td><td>74.7, d </td></tr><tr><td>3' </td><td>\u00a0</td><td>77.9, d </td><td>\u00a0</td><td>78.0, d </td></tr><tr><td>\u00a0</td><td>3.29~3.45, m </td><td>\u00a0</td><td>3.22~3.40, m </td><td>\u00a0</td></tr><tr><td>4' </td><td>\u00a0</td><td>71.7, d </td><td>\u00a0</td><td>71.5, d </td></tr><tr><td>5' </td><td>\u00a0</td><td>78.1, d </td><td>\u00a0</td><td>78.2, d </td></tr><tr><td>6' </td><td>3.92, dd, J=11.6, 2.0 Hz </td><td>63.1, t </td><td>3.86, d, J=11.6 Hz </td><td>62.6, t </td></tr><tr><td>\u00a0</td><td>\u00a0</td><td>\u00a0</td><td>3.70, dd, J=11.6, 6.0 Hz </td><td>3.66, dd, J=11.6, 5.2 Hz </td></tr></table></body></html>"}, "TABREF4": {"text": "Table S2. Effects of 3,5-DCQA on O 2\u2022\u2212 generation and elastase release in fMLF-or LTB4-induced human neutrophils", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Inducers </td><td>IC50 (\u2022M)\n</td></tr><tr><td>O2\n\u2022\u2212 generation </td><td>elastase release </td></tr><tr><td>fMLF </td><td>1.92 \u00b1 0.54 </td><td>12.02 \u00b1 0.60 </td></tr><tr><td>LTB4 </td><td>\uff0d </td><td>2.90 \u00b1 0.55 </td></tr></table></body></html>"}, "TABREF5": {"text": "Table S3 Table S3. HNE inhibitory activities of caffeic acid analogs", "latex": null, "type": "table", "html": "<html><body><table><tr><td>Compounds </td><td>IC50 (\u2022M)\n</td><td>Inh %a </td></tr><tr><td>1 </td><td>&gt; 30 </td><td>-2.99 \u00b1 1.35 </td></tr><tr><td>2 </td><td>&gt; 30 </td><td>-3.43 \u00b1 4.85 </td></tr><tr><td>3 </td><td>&gt; 30 </td><td>-4.76 \u00b1 3.36 </td></tr><tr><td>4 </td><td>&gt; 30 </td><td>9.91 \u00b1 0.99 </td></tr><tr><td>6 </td><td>1.86 \u00b1 0.06 </td><td>90.53 \u00b1 0.52 </td></tr><tr><td>7 </td><td>&gt; 30 </td><td>36.42 \u00b1 2.25 </td></tr><tr><td>CA </td><td>&gt; 30 </td><td>-4.61 \u00b1 4.03 </td></tr><tr><td>p-CA </td><td>&gt; 30 </td><td>-4.00 \u00b1 3.42 </td></tr><tr><td>3-HCA </td><td>&gt; 30 </td><td>-3.63 \u00b1 3.91 </td></tr><tr><td>FA </td><td>&gt; 30 </td><td>0.06 \u00b1 4.79 </td></tr><tr><td>RA </td><td>&gt; 30 </td><td>10.58 \u00b1 4.03 </td></tr></table></body></html>"}}, "back_matter": []}